Yes, there is a well-established link between bipolar disorder and ADHD
Bipolar disorder and ADHD frequently co-occur, with comorbidity rates ranging from 18-25% in adults and even higher in youth populations, representing a clinically significant association that far exceeds what would be expected by chance alone. 1, 2, 3, 4
Clinical Evidence of Association
The relationship between these disorders manifests in several key ways:
Comorbidity Patterns
- In pediatric populations: Comorbid ADHD is common enough that clinical guidelines specifically address treatment sequencing 1
- In adult BD patients: Studies consistently show 17.9-25% have comorbid ADHD, with childhood-onset ADHD (BD+cADHD) being particularly significant 5, 2, 3, 4
- Gender differences: Males with bipolar disorder show higher rates of comorbid ADHD 2
Clinical Impact of Comorbidity
When ADHD and bipolar disorder co-occur, patients experience worse outcomes:
- Treatment response: Comorbid ADHD predicts poorer response to mood stabilizers, particularly lithium and lamotrigine 1, 5
- Illness severity: More anxiety disorders, substance use disorders, and suicide attempts 5, 2, 3, 4
- Earlier onset: BD patients with childhood ADHD show younger age at BD onset 4
- Social functioning: More unemployment, lower socioeconomic status, higher divorce rates 2
Genetic Evidence
The genetic overlap between these disorders is substantial and provides biological evidence for their association:
- SNP-based genetic correlation: A highly significant correlation of 0.64-0.71 exists between ADHD and BD, particularly strong with early-onset BD 6
- Polygenic risk scores: BD patients with childhood ADHD show elevated ADHD polygenic risk scores compared to BD patients without ADHD 5
- Shared genetic loci: Genome-wide association studies have identified specific chromosomal regions (chromosomes 5,6, and 10) associated with both conditions 6
Clinical Management Implications
Treatment Sequencing
For patients with clearly defined bipolar disorder and comorbid ADHD, stimulant medications can be safely used to address ADHD symptoms ONLY after mood symptoms are adequately stabilized on a mood stabilizer regimen. 1
The evidence supporting this approach:
- A randomized controlled trial demonstrated that low-dose mixed amphetamine salts were safe and effective for treating comorbid ADHD once mood was stabilized with divalproex 1
- Stimulant use for comorbid ADHD did not affect relapse rates in stabilized patients 1
Critical Diagnostic Pitfall
More than 40% of BD patients who screen positive on ADHD rating scales (ASRS) do not actually have ADHD upon clinical assessment 4. This false-positive rate is particularly high in patients with severe BD course, meaning:
- Screening tools alone are insufficient for diagnosis in BD populations
- Clinical assessment by a specialist is essential before diagnosing comorbid ADHD
- Mood lability and irritability from BD can mimic ADHD symptoms
Developmental Considerations
The guidelines emphasize that in children where the distinction between ADHD with mood lability versus true mania is unclear, studies show that boys with ADHD plus manic-like symptoms respond equally well to methylphenidate as those without manic symptoms, and stimulant treatment does not precipitate progression to bipolar disorder 1. However, 58% of youth with juvenile BD experienced emergence of manic symptoms after exposure to mood-elevating agents 1.
Theoretical Models
Recent research proposes four potential scenarios explaining the ADHD-BD relationship 7:
- Shared genetic/neurobiological pathways (supported by genetic correlation data)
- ADHD as a prodrome or risk factor for BD development
- Overlapping symptom criteria leading to diagnostic confusion
- True independent comorbidity of two distinct disorders
The substantial genetic correlation (0.64-0.71) 6 and elevated ADHD polygenic risk scores in BD+cADHD patients 5 most strongly support shared biological mechanisms rather than mere diagnostic overlap.